| abstract |
Provided are a medicinal composition for neovascular diseases, a medicinal composition inhibiting neovascularization proliferation factor, and utilization of these compositions. In one or more embodiments, the present invention provides a medicinal composition that comprises, as an active ingredient, a low molecular compound capable of suppressing the expression of a VEGF gene in cells or reducing the production of a VEGF protein by cells. In one or more embodiments, the present invention provides a medicinal composition that comprises, as an active ingredient, a compound represented by general formula (I), a prodrug thereof, or a pharmaceutically acceptable salt of the same. |